2019 Faculty

Gail Adinamis
CEO & Founder
GlobalCare Clinical Trials, USA

Gail Adinamis is the CEO and Founder of GlobalCare Clinical Trials. She has over 35 years of comprehensive phase I-IV clinical trials experience including over 12 years of global clinical trials management at Abbott Laboratories and Astellas Pharma US. She founded the business model for centrally managed homecare services for clinical trials in 1992.

Effie Atkins
Research Study Patient

Research Study Patient
Diagnosed with liver cancer, Effie’s life was turned around when she agreed to participate in a phase 1b trial at the Monash Health Translation Precinct. Her liver tumour has shrunk, and over 2 years later she remains in good health. She has met many others with similar stories. Recently Effie discovered that, with more support for such trials, many more patients could benefit from similar clinical trials and research to find improved treatments could advance much faster. Today, Effie works to spread the word, gain support in her own community, and eliminate key funding bottlenecks. She works with Monash Health to raise funds to help cancer patients who have exhausted all other treatment options.

Bernadette Aliprandi-Costa, PhD
Manager, Safety and Quality Improvement Systems and Intergovernmental Relations
Australian Commission on Safety and Quality in Health Care, Australia

Zoe Armstrong, BSc (Biotechnology)
Clinical Research Director ANZ
MSD, Australia

Zoe began her career in the pharmaceutical industry 20 years ago at MSD. She started in clinical operations as a CTC then CRA, moving through various functional roles including, project mgt and line mgt for 10 years. In 2009 Zoe assumed the role of research director for Australia and NZ and supported the clinical operations team through the subsequent merger with Schering Plough and the combination of Aus and NZ into one cluster ANZ. For the last 9 years Zoe has led research operations as CRD across ANZ. From 2013-2015, Zoe also lead the ASEANZ cluster where she assumed responsibilities for countries across South East Asia in addition to ANZ. Now she manages a broad team of 144 people across ANZ and offers unique insight into the opportunities and challenges with leading clinical trials across countries and diverse cultures. Zoe holds a BSc (Biotechnology) from the University of Technology Sydney.

Georgina Arnold
Clinical Research Director for South East Asia

Georgina joined MSD in 2004 and is now the Clinical Research Director for SEA. Within this role, she leads, manages and oversees all aspects of MSD’s clinical operations across the cluster (Philippines, Vietnam, Singapore, Thailand, Malaysia and India).
Georgina offers over 20 years of industry experience in both APAC and Europe across different phases of clinical trial, therapeutic areas, and in CRO and Pharma environments.

Sophy Athan, BA, MA, Grad Dip Lib, Grad Dip Lib Soc Pol
Chair CCAC
VCCC, Australia

I have been a consumer leader and advocate for the last 17 years. I became first invovlved with health because of my role as a carer to 2 family members. I have been on a numerous committees in the acute sector and in the primary sector. Over the last 3 years I have become involved more closely with research and education on committees and also on research grants. I am the Chair of the Health Issues Centre (Victorian Peak Consumer Organisation), AHPRA CRG, EMPHN CRG, Victorian Clinical Council member, Chair of Cancer Consumer Advisory Committee of the VCCC plus others. I am passionate and committed to improving quality and safety outcomes for patients and one way to achieve this is to involve patients/consumers in research and clinical trials. I have undertaken a number of consumer leadership courses and have acommitment to improving access and equity to all aspects of health

Dom Bailey, MClinTRes; MOHS; B.Nurs,
Genesis Research Services, Australia

Dom has studied Nursing, Occupational Health and Safety and Clinical Trials Research at University and is a highly experienced healthcare professional having worked extensively in both public hospitals and private companies. Dom has conducted clinical research workshops, webinars and presentations locally and internationally on Quality Management, Social Media in Clinical Trials, Medical Device Studies, and Site Development. Over 5 years he has led the development of Genesis Research Services from a small clinical trials practice into a multi-service company that manages multiple specialist investigators, international modern recruitment services, a research network, a registry of over ten thousand trial participants and obtained ongoing ISO9001 Quality Management Accreditation for all aspects of the business. With a focus on business development, innovation and sustainability, Dom’s professional goal is to provide simple and valuable quality management for clinical research success.

Wayne Baker
Greenphire, USA

As Greenphire’s Chief Commercial Officer, Wayne is responsible for the global commercial strategy of the rapidly growing organization, including the execution of sales and marketing programs. Wayne is a proven strategic sales executive with more than 25 years of commercial experience in technology and life science industries. Prior to joining Greenphire in 2016, Wayne served in numerous senior leadership roles at Advanced Health Media (AHM), a leading global provider of SaaS-based solutions designed to manage compliant interactions with healthcare professionals and organizations. During his tenure, Wayne helped establish AHM as the market leader, playing an integral role in the organization’s 1500 percent revenue growth during a four-year period. Earlier in his career, Wayne gained sales leadership and industry experience at Parametric Technology Corporation (PTC) and Brent International. He earned his bachelor’s degree in Chemical Engineering from Drexel University. Wayne resides in the Philadelphia area with his wife and four children.

Charlotte Bradshaw
CEO & Co-founder
Evrima, Australia

Experienced patient recruitment specialist with strong project management and digital marketing expertise across various therapeutic areas and trial phases. Client-focused and driven to achieve innovative solutions.

Radhika Butala
Manager, Clinical Trials Unit
Macquarie University, Australia

I’ve been in the Clinical Research Industry for more than 15 years now, having worked across different streams in both Drug and Device trials. In 2013 I started the  Clinical Trials Unit for the Faculty of Medicine and Health Sciences at Macquarie University in Sydney, Australia.  In the past 5 years the CTU has grown to a 18 member strong team that currently coordinates over 50 trials spread across various clinical streams. I’ve been an active member of the SCRS ASIA-Pac summit from its inception in 2014 and am always keenly interested in incentives that benefit site metrics.

Lee Byrne, BA, GradDip.Journ, MA
Communications Manager
Victorian Comprenhensive Cancer Center, Australia

A successful track record in delivering complex communication strategies and campaigns, particularly in integrating content and audience segmentation across multiple platforms. Lee Byrne has nearly 20 years’ experience in a range of sectors, including education, government, science and health, both here and in the UK. She has a reputation for achieving solutions through a collaborative approach, incorporating stakeholder management and engagement opportunities. In her most recent appointments, Lee has delivered organisational change, increased staff engagement, managed development of inactive websites, connected and engaging social media accounts, facilitated strategic collaboration opportunities and developed leading teams. Lee currently works for the Victorian Comprehensive Cancer Centre (VCCC), with a focus on increasing access, participation and workforce capability in cancer clinical trials. The VCCC is a multi-site, multi-disciplinary alliance of 10 leading research, academic and clinical institutions working together to identify and fill gaps and unmet needs, to benefit the critical mass and improve outcomes for Victorian cancer patients.

Carlos China
Regional Clinical Site Lead
Pfizer, Australia

Matthew Cook, PhD
Senior Clinical Site Monitor
Bristol-Myers Squibb, Australia

Matthew Cook is a Senior Clinical Site Monitor at Bristol-Myers Squibb Australia where he has worked since May 2015. Prior to this, he worked as a study coordinator on haematology, oncology, and phase I clinical studies. He has background in cell biology, working as a Research Associate/Specialist Scientist in both Australia and the United Kingdom. Matthew holds a PhD (Cell Biology), Bachelor of Science with Honours and a Graduate Certificate in Technology and Innovation Management all from the University of Queensland. Matthew has a strong focus on improving patient outcomes and on establishing strong relationships with clinical research sites.

Kyle Cunningham
Chief Product Officer
Greenphire, USA

As Chief Product Officer, Kyle leads the strategic direction of Greenphire’s solution development, ensuring that our product innovation roadmap is constantly evolving to solve relevant healthcare industry problems - ultimately creating value for sponsors, CROs, clinical research sites and study participants. Kyle has two decades of experience across multiple industries and in a variety of roles spanning innovation, operations management and client experience. Prior to joining Greenphire, Kyle worked for SEI Investments (Europe) where he managed product and service innovation for global asset management.

Madeleine Do
Senior Global Trial Manager
Janssen Cilag, Australia

Executive Coach
AltusQ Pty Ltd Australia

Tim helps people and businesses to help themselves – to develop and grow towards where they need to grow – aiming to reach new heights. To give passion to their strategy and to give strategy to their passion. Following a life in veterinary practice, academia and government, Tim turned his mind and business efforts to coaching people and also consults in research ethics, integrity and govenance. His passion is ‘the accidental leader’ – the scientist / practitioner / clinician who is promoted to a manager role – where soft skills are essential.

Suzanne Elliott
Clinical Trial Unit Manager
Gallipoli Medical Research Foundation, Australia

Suzanne Elliott joined the Foundation in November 2016 as the Clinical Trial Unit Manager. Suzanne has been involved in clinical research for over 25 years, with a doctorate in molecular oncology and post-doctorate in infectious/viral/cancer immunology clinical trials. She has a special interest in early phase drug development, Phase I clinical trials, working with a Phase I company for over a decade. She has qualifications in drug development and has extensive experience particularly in ethics and regulatory affairs and Good Clinical Practice. Suzanne’s focus is to provide a professional and supportive role to the Foundation’s clinical team in its aim to pursue clinical research excellence in emerging new therapies that may benefit our patients.

Lorena Figueroa, B.Pharm
Country Clinical Operations Leader
Roche, Australia

Lorena is passionate about harnessing people's talents and strengths in order to bring hope to patients through efficient delivery of quality clinical trials. She strives to create an environment of trust, collaboration and adaptability where people feel encouraged to be authentic and supported to excel.
Current Role Lorena joined Roche in 2015 as a Country Clinical Operations Leader, managing a team Regional Project Managers support the delivery of clinical trials and process improvement projects. Lorena is a member of the e-label transcelerate APAC working group representing Roche. Experience Lorena has 20 years’ experience as Global Project and People Manager, both in Pharma and Biotech. Lorena holds a degree of Pharmacy from the University of Buenos Aires and a diploma in Project Management from UNE. Personal note / Fun fact Lorena is interested in mindfulness and regularly practices yoga, meditation and Reiki and is currently learning pottery.

Diana Foster, PhD
Vice President, Strategy and Special Projects

Diana Foster, PhD, is the Vice President of Strategy and Development for the Society for Clinical Research Sites and is responsible for building relationships with industry that help amplify the voice of the clinical research site. She is a recognized expert in the intricacies of site management and an innovator in the use of strategic marketing tactics. Diana has designed and facilitated site management and patient recruitment trainings across the globe.

Melanie Gentgall, RN
PRAXIS, Australia

Melanie has spent the last 20 years of her career within the Australian Clinical Trials environment and has seen it progress from a fledgling industry to its current advanced and exciting network across Australia. She is a passionate and dedicated research advocate who is committed to improving access to education and training of the highest quality for the entire Australian research sector. This is made possible through her current role as founding CEO of PRAXIS Australia, a NFP education provider fast becoming a leader in the Australian sector through various models including its flagship training model, Research Essentials.

Angela Giagodi
Creative Touch Coaching & Training, Australia

Angela Giagodi is a Certified Learning & Development Consultant and Coach. She has over 22 years’ experience in the clinical research industry in a variety of roles. Since 2015, Angela has been working as a consultant, where works directly with clients to meet their learning and performance needs.

Loretta Gierck
Senior Site Start Up & Regulatory Specialist
Syneos Health, Australia

Encompassing over 11 years of experience within the Ethical and Governance framework with expertise in Faciliatation, Preparation and Execution of Ethics/Governance Submissions, Budgets/Contracts, PICF Writing and Regulatory Submissions from an Ethics Office, Site Trials Unit and CRO perspective.

Siew Lee Goh, PhD
Director, Site and Patient Access
Syneos Health, Singapore

Siew Lee received her Bachelor of Science (Hons) in Biochemistry and Microbiology & Immunology and Master of Science in Biochemistry from Dalhousie University in Canada and her Doctor of Philosophy in Experimental Medicine from McGill University in Canada. She is currently holding a position as Director, Site and Patient Access at Syneos Health in Singapore. She is responsible for delivering and implementing site relationship initiatives in Asia Pacific region in line with the company’s global strategy.

Cheryl-Ann Hawkins, RN, MHA
Senior Research Manager, Medical Oncology
Monash Health, Australia

Cheryl-Ann Hawkins is currently the Clinical Research Manager of Oncology at Alfred Health. She is the Australian Ambassador for the Society for Clinical Research Sites (SCRS) and Chair of SCRS AsiaPac Summit 2019. Cheryl-Ann has a keen interest in supporting study sites and improving processes to ensure sites can cope with the demands of providing clinical trials to patients. She has worked in various leadership Oncology nursing roles in a career spanning 25 years. Over the past 15 years she has focused her career on early phase/first in human drug trials, recently moving into her research manager role to broaden her management experience. Cheryl-Ann completed a post graduate diploma in Oncology/Palliative care nursing in 1996, a Master degree in Health Administration in 2004 and a post graduate certificate in Oncology Research in 2012. Cheryl-Ann holds an affiliate position with Monash University/ Monash Partners educating and certifying researcher in Good Clinical Practice (GCP).

Kylie Hewitt, PhD, Bsc (Hons)
Senior Country Manager

I received my Bsc Hons in 1999 and completed a PhD in biochemistry and molecular biology in 2003, both from Monash University. Worked in research at the University of Birmingham from 2004 -2007, focusing on obesity and hormones. Then joining the University of WA as a Research Associate genetic epidemiology research in the therapeutic area of cancer (Mesothelioma, Prostate, Breast, Brain and Skin cancer) 2007 to 2008. From 2008 to 2011 I worked on phase II and III multi-site clinical trials in the therapeutic area of Oncology as Study Coordinator at Peter MacCallum Cancer. Then joining PPD in 2011 as a submission specialist and in 2013 the start-up manager for Australia New Zealand, since then I have taken start up activities in managing Singapore, Malaysia & the Philippines.

Andrew HuxleyAndrew Huxley, MBA
Regional Director, Clinical Operations for Asia Pacific
Eli Lilly and Company, Australia

Andrew Huxley is currently the Regional Director of Clinical Operations for Eli Lilly within Asia Pacific. Through a number of roles Andrew has had over 15 years’ experience managing virtual teams and working with CROs in Asia Pacific and across the globe. In this most recent role, he has been responsible for leading a functional sourcing model and driving organisational change, which is intended to provide improved sense of partnership and customer focus. With a Bachelor of Science and MBA in Project Management and Marketing, Andrew is passionate about effectively integrating business with science. Other topics of interest include staff engagement, balanced scorecards and developing high performance teams.

Gina Kennedy, MS
Senior Clinical Operations Manager
Covance, Australia

Gina has worked in the clinical trials industry for over 20 years, including pre-clinical laboratories, at site, in pharma and CROs. Her roles across the industry, including pharmacologist/scientist, study coordinator, CRA, project management, and various departmental management and mentoring roles. With Gina’s varied background of the industry she brings a holistic approach to managing clinical trials, and has a great understanding of all stakeholder perspectives and works to try to harmonise and align all stakeholders to better treat our families and friends.

Kimberly Kundert, RN, BSN
VP, Operations
VirTrial, USA

Kim Kundert is an experienced research executive and currently VP of Clinical Operations for VirTrial. Prior to VirTrial, she served as the SVP of Operations for Radiant Research/Synexus, the largest site network in the world. Kundert was responsible for overseeing operations and performance of 84 research sites across the US. In her 19 years at Radiant, Kundert helped develop a platform of standardization across the network sites and had some hand in approximately 10,000 trials. Kundert has served on pharmaceutical advisory boards and CRO planning committees to provide input on protocol development and enrollment strategies from a site’s perspective. Kundert is a winner of two Stevie Awards for women in Business- Best Executive in Service Businesses in 2011, Silver Stevie for Female Executive of the Year in 2012. Kundert graduated Summa Cum Laude from Arizona State University with a bachelor’s degree in Nursing.

Bill Lam, PhD, MBChB
Director, Clinical Site Management
Pfizer, Australia

Bill Lam is Director, Clinical Site Management, Pfizer Australia & New Zealand. He joined Pfizer Australia as Associate Medical Director in 1999. Over the last 18 years, Bill has taken up roles of increasing responsibility in Medical Affairs and Clinical Development. Bill moved to Pfizer HQ, New York in 2004 as Regional Medical Director of Japan/Asia in cardiovascular medicine. In 2009, he became the Clinical Development Lead of Emerging Markets for medicines in the treatment of heart & thromboembolic diseases, pain, Alzheimer’s disease, and haemophilia. In 2012, Bill was the Medical Affairs Lead of Asia, leading medical affairs initiatives for Pfizer’s innovative compound portfolio in internal medicine, inflammation & immunology and rare diseases. Bill has recently returned to Australia to lead the Global Clinical Site Management team who delivers Phase 1-3 global clinical trials in Australia and New Zealand.

Kurt Lackovic, PhD, MBA, GAICD
Cancer Trials, Australia

Dr Lackovic has led Cancer Trials Australia (CTA) through significant growth over the past two years. As CEO of CTA, he is responsible for the development and implementation of CTA’s strategy, including business development and stakeholder engagement, as well as general operations. He has spent his entire career in medical research. His education includes a PhD in chemistry, post-doctoral placements in medical genomics and early stage drug discovery, as well as an MBA from Melbourne Business School, where he graduated on the Dean’s list. Dr Lackovic has published 23 peer-reviewed articles across diverse medical research areas, possesses extensive expertise in leading complex academic and clinical programs, strong connections to industry, and strategic linkages to senior executives in Government and major teaching Hospitals. He is a member of the Licensing Executives Society of Australia and New Zealand, American Society of Clinical Oncology, Society for Clinical Research Sites and AusBiotech’s Clinical Trials Advisory Group.

Marian Lieschke, RN
Parkville Cancer Clinical Trial Unit, Australia

Marian Lieschke trained as a an Oncology Nurse at the Royal Marsden. After moving to Australia, she worked extensively as a Clinical Oncology Research Nurse becoming the the Manager of the Royal Melbourne Hospital Oncology Clinical Trials Unit in 2004. She was appointed as the Manager of the Parkville Cancer Clinical Trials Unit (PCCTU) in 2016, bringing the trial units of RMH , the Peter MacCallum Cancer Centre and the Royal Womens Hospitals together as a single unit to serve the Precinct, a unit which now employs nearly 100 staff. Marian has held positions in the Victorian Association of Research Nurses and the Cancer Council of Victoria Clinical Trials Professionals Group and currently chairs the VCCC committee on Building Workforce Capacity. Marian is passionate about Clinical trials as an alternate clinical pathway for patients, about education for Clinical trial staff and for improving the Clinical trial industry by increasing conversation with global Pharmaceutical companies.

Lauren Macnaughton
Site Engagement Manager
Eli Lilly, Australia

Lauren Macnaughton currently leads the Site Engagement Teams for Australia, New Zealand and India at Eli Lilly. These teams are responsible for partnering with clinical trial sites to execute clinical research projects across a variety of therapeutic areas. She has over 14 years experience in clinical research across a variety of project and people leadership roles at local, regional and global levels. Lauren is passionate about making a difference in the lives of patients by facilitating access to innovative treatment options through clinical trials. Lauren holds a Bachelor of Science in Molecular Biology & Genetics from the University of Sydney.

Robin Marcus, RN, BSN
Chief Strategy Officer
GlobalCare Clinical Trials, USA

Robin Marcus is Chief Strategy Officer with GlobalCare Clinical Trials. Over the past 28 years Robin has become known as an innovative healthcare executive focused on operationalizing new products and services. Her talents have been leveraged with companies of all sizes including Caremark, Mediware, Home Healthcare Laboratory of America, and Integrity Health Care. She began her professional career as a an Oncology and Bone Marrow Transplant Nurse in San Francisco after receiving her BA from University of California San Diego and her BSN from The University of San Francisco.

The Honourable Frank McGuire, MP
Parliamentary Secretary for Health & Medical Research
Victorian Government, Australia

Clare Mena, BBiotech
Budget & Contracts Specialist
Cancer Trials, Australia

Clara Mena is a Budget and Contracts Specialist at Cancer Trials Australia where she has worked since 2017. Prior to this, she worked as a Clinical Research Associate at inVenitv Health Clinical and PAREXEL. Clara has a strong focus on establishing strong relationships with sites and sponsors and improving overall study start up timelines. Clara holds a Bachelor of Biotechnology.

Sophie Mepham, PhD
National Research Manager
Genesiscare, Australia

Sophie has worked in clinical research since 1997 and is currently National Research Manager for GenesisCare, specialising in research that focuses on Theranostics, medical oncology and radiotherapy treatments. Sophie previously worked as Senior Manager, Translational and Clinical Research and for 3 years as the Head of the Clinical Trials Unit at Peter Mac, covering all specialities of oncology trials, from first in human, through to phase III. Before taking up this role in Australia, Sophie worked in the UK managing a haematology clinical trials unit for 8 years and then subsequently for 2 years as a Research & Development Manager for all clinical research across a large NHS hospital as part of the National Institute for Health Research (NIHR). She has a PhD in Oncology/Immunology and is an NIHR accredited GCP trainer and GCP program lead.

Dan Milam
Vice President Global Engagement

With over twenty years of experience working in the pharmaceutical, CRO, and site sectors, Dan has gained a wide perspective and understanding of the needs of the industry as a whole that aid to facilitate and build strong alliances. His focus is on expanding SCRS’ global footprint and the inclusion of all industry stakeholders in SCRS initiatives with the goal to foster sustainability for clinical research sites.

Megan Morrison, MBA
Country Head
Covance, Australia

Eman Nafea, PhD
Clinical Trials Education, Training & Development Manager
Peter MacCullum Cancer Centre, Australia

Sumith Nawaratne, PhD, BSc (Hons)
Senior Project Manager
PRA Health Sciences Australia

Sumith holds a BSc (Hons) from Monash University in Pharmacology and a PhD from the Victorian College of Pharmacy/Austin Hospital in Clinical Pharmacology and Pharmacokinetics. He has been engaged in clinical research, project management, pharmacovigilance, clinical training, clinical compliance and medical marketing for the last 22 years. In that time, he has worked for CSL, PPD, Mayne Pharma, Hospira Australia and Clinuvel Pharmaceuticals. He was also the project manager for the Australia Thai HIV vaccine Consortium, for which he was responsible for the GLP, GMP and GCP development of two HIV vaccine candidates. He has experience in all areas of pharmaceutical/biotechnology product development from conception to market approval and medical marketing, with his strength in clinical development.
During his time in the pharmaceutical industry, he has held concurrent appointments as a Senior Fellow in both the Radiology and Microbiology/Immunology departments of Melbourne University and was an ARCS Board member. He is a current member of the Australian Institute of Company Directors and a Fellow of the Australian Institute of Project Managers.
He completed his role as the Director for Clinical Research & Compliance at Clinuvel Pharmaceuticals, responsible for all global clinical research activity for the lead product, SCENESSE®. In October 2014, SCENESSE® was approved by the EMA . This work was also published in the New England Journal of Medicine July 2015.

Maureen Nicholls, BSc Pharmacy
Country Clinical Operations Leader
Roche, Australia

I started out my career as a pharmacist working in retail and hospitals and discovered clinical trials when I moved to Australia. I have now worked in the Pharmaceutical industry for 19 years both in a CRO and Pharma and have been fortunate enough to work with amazing people who are dedicated to helping patients get access to life changing medicines. I have held a number of different positions and currently really enjoy managing a team of experienced project managers managing trials across Asia Pacific. I am passionate about people and patients and consider myself lucky to be able to work in this industry doing so much great work. .

Tam Nguyen, PhD, MBA
EO Research
St. Vincent's Hospital Melbourne, Australia

Dr. Tam Nguyen is an experienced research administrator with previous clinical research experience in biomedical engineering at numerous teaching hospitals and medical research institutes across Australia. In the current role as a senior executive of research at St Vincent's Hospital Melbourne, he is responsible for research strategy, business development and administration. He has a double degree in Biomedical Engineering, a PhD in Biomechanics and an MBA in general management. Tam is an Adjunct Associate Professor at RMIT University and an Honorary Senior Fellow at the University of Melbourne. He is a fellow of the Australian Institute of Management and a member of the Australian Institute of Company Directors. Tam recently co-founded an investment fund supporting Australian biotech and medtech start-ups.

Casey Orvin

Casey Orvin is President of the Society for Clinical Research Sites (SCRS). With nearly 20 years of experience working with the site community, Orvin previously served as Executive Vice President of Business Development for Synexus, and Vice President of Marketing and Sponsor Recruitment for Clinical Research Advantage.
Orvin is a champion for clinical research sites with experience creating outreach programs, developing key partnerships, and generating study opportunities for hundreds of clinical research sites globally. He is an active community member and dedicated volunteer in the Phoenix area where he lives with his wife and three children.

Sarah Poriters
Country Clinical Operations Leader
Roche, Australia

I have worked in clinical research for more than a decade, starting as a Study Coordinator at a small private practice working in HIV. I joined Roche in 2010 and have worked as a CTA, CRA, Project Manager and Clinical Research Manager. Working within our Oncology team I have a particular focus on lung and breast cancer. Recently I’ve been supporting our team members who are implementing the Teletrial model on their studies and I am very excited about this opportunity to bring trials to patients in rural Australia.

Amanda Rangel, MS, CCRC
VP of Business Development
VirTrial, USA

Amanda has spent 15 years in the clinical research industry serving a variety of functions including clinical research coordinator, patient recruitment and engagement specialist, business development, and head of operations for a US based site network. Most recently, Amanda served as Sr. Director, Global Business Development for Synexus, the largest site network in the world. Amanda is now fortunate to help lead VirTrial's integration of telehealth into the clinical research industry.

Teresa Ringeri, RN Div.1; BAppSc(Psych); BNurs
Business Manager, Senior Clinical Research
Emeritus Research, Australia

Experienced Senior Clinical Research Coordinator and Business Manager at Emeritus Research, which is a dedicated Clinical Research Centre. Has worked in the pharmaceutical clinical trials industry for over 8 years and recently moved into the Business Manager position, which involves managing studies from the point of feasibility, and assessing their suitability for our site, up until the point of Site Initiation Visit. Skilled in Good Clinical Practice (GCP); setting up and running clinical trials; maintaining excellent relationships with clients, study participants and staff; Mentoring; Leadership; and Business Development. Strong research professional with a Bachelor of Nursing/Bachelor of Applied Science from Deakin University. Loves being at the forefront of cutting edge clinical trials that provide new treatment options and benefits for trial participants.

Dr. Megan Robertson
Director of Research
St. Vincent's Hospital Melbourne, Australia

Dr. Megan Robertson is an alumna of the University of Melbourne where she completed a Bachelor of Medicine, Bachelor of Surgery (MBBS). She is the current Director of Research at St Vincent’s Hospital, Melbourne, and works as a Senior Intensivist at Epworth HealthCare, and Assistant Censor at the College of Intensive Care Medicine (CICM). Previously, she held positions as the Director of Professional Affairs, CICM, as the Executive Director of Research at Epworth HealthCare, and as the Co-Director of the Intensive Care Unit at Epworth Freemasons.

Natasha Rogic
Regional Site Advocate
Vertex Pharmaceuticals, Australia

Natasha Rogic is a clinical research professional with over six years’ experience in the Australian and New Zealand clinical trials industry. Natasha holds a Bachelor’s degree in Science (Pharmacology) from the University of Sydney and has therapeutic experience in Cystic Fibrosis, Oncology, Haematology, Neurology, Immunology and Rare Diseases. Currently serving as Regional Site Advocate and Regional Clinical Operations Study Lead at Vertex Pharmaceuticals, Natasha has also held the roles of Site Activation Manager, Clinical Research Associate and In-House Clinical Research associate at PRA Health Sciences and AstraZeneca. Natasha has a passion for improving patient outcomes and supporting clinical research sites by removing obstacles between study sponsor and investigative sites in addition to reducing site and patient burden.

Mark Rosenthal, PhD, MBBS, FRACP
Parkville Cancer Clinical Trial Unit, Australia

Professor Mark Rosenthal trained as a Medical Oncologist in Melbourne and Sydney, Australia. He was awarded a Doctorate of Philosophy for a thesis examining the molecular genetics of colon cancer conducted at the Ludwig Institute for Cancer Research. (1992-1996). He completed post-graduate training at New York University Medical Centre, New York, USA (1996-98) was a Senior Staff Specialist in the Department of Medical Oncology, Royal Melbourne Hospital (1998-2016) and Professor Director of the Department from 2006-2016. He was Chairman and Chief Medical Officer of Cancer Trials Australia (2006-2016) and was Chairman of the Cooperative Trials Group for Neuro-Oncology (COGNO) from 2007-16. In 2016 he was appointed as: Senior Staff Specialist in the Department of Medical Oncology at the Peter MacCallum Cancer Centre, Director of the Parkville Cancer Clinical Trials Unit and Clinical Trials Lead for the Victorian Comprehensive Cancer Centre. His major interests include: neuro-oncology and early phase clinical trials.

Archana Sah, BSc (Pharm), MSc (Pharm), PMP
Therapeutic Area Leader, Oncology
Genentech, member of Roche Group, USA

Archana Sah is a Clinical Research and Development executive with over 22 years end-to-end leadership experience in developing medicines for patients having led and contributed to several FDA/EMEA drug approvals in Immuno-Oncology, Precision therapeutics, Rare Diseases, Metabolic Diseases and Women's Health. She is a strategic expert on emerging topics ranging from therapeutic landscape/treatment trends expertise to business strategy, planning and operations. In her current role as the Therapeutic Area Leader, Oncology at Genentech/Roche, she provides therapeutic area expertise, strategic direction and operational leadership for delivery for Phase I-III oncology portfolio trials in the North America region. She is the co-chair of the Oncology Board along with Christine Pierre at the Society for Clinical Research Sites with a mission to cure cancer through efficiency in processes and strength in the partnership between clinical research sites, pharmaceutical companies, and patients.

Adam Stoneley
Research Operations Manager
Icon Cancer Foundation, Australia

Adam Stoneley is the Clinical Trial Operations Manager for the Icon Group, Australia’s largest dedicated provider of cancer care. Adam is a firm advocate of the Group’s simple vision to deliver the best care possible to as many people as possible, as close to home as possible.

Courtney Thornley. BSc
Program Manager
Victorian Comprehensive Cancer Centre, Australia

A passionate and committed healthcare professional with an array of experience in both clinical and translational research in oncology, culminating in an extensive working knowledge of both the healthcare and academic sectors. As a professional, Courtney Thornely takes a continuous approach to evaluation and is constantly seeking agile ways to improve processes and procedures; achieving mutual satisfaction of all parties involved. A strategic thinker, Courtney enjoys the opportunity to apply experience and knowledge for continuous improvement, and uses these skills as a program manager to further develop engaging communication and beneficial relationships to build trust with key stakeholders and opinion leaders.

Elizabeth Wilson, BPharm, PGDipClinPharm
Associate Director, Prime & Partner Sites ANZ
IQVIA, Australia

Elizabeth worked initially in hospital and retail pharmacy roles before moving to the biopharmaceuticals industry. She has since worked in various clinical development and management roles with Agenix Ltd, Progen Pharmaceuticals Industries Ltd, and QuintilesIMS. Elizabeth is currently Associate Director for Sites Relationships for IQVIA Australia-New Zealand. Elizabeth completed her degree in Pharmacy (University of Queensland) and has postgraduate qualifications in clinical pharmacy. She has spent more than 20 years focusing on clinical hospital pharmacy and drug development, particularly in the area of clinical cancer services for paediatric and adult patients. Her current role involves working with sites and sponsors to increase the speed and efficiency of patient recruitment and clinical research in Australia and New Zealand to bring new medicines to patients faster.

Felicity Wilson
Study Start Up Manager
Roche, Australia

Clinical Operations Manager in pharmaceuticals with over 10 years clinical trial experience including 6 years in Study Start Up. I lead a highly engaged team of Study Start Up Specialists at Roche Products who have implemented novel submission strategies such as direct sponsor submissions. My mission is to achieve positive business outcomes through realising people's potential. I do this through my coaching, learning, strategic and agility capabilities. I am motivated by my team creating hope and clinical trial opportunities for patients in need of enhanced treatment options.

Christine Zahren, BSN, RN, MAppSC (Acu)
Business Development Manager
ClinTrial Refer, Australia

Christine has a background in nursing with over 25yrs experience in the healthcare Industry. She has worked in various areas including aged care, acute care, rehabilitation medicine, dermatology specialist clinics, and surgery. Christine has extensive experience as a clinical trial nurse coordinator, and spent 5 years managing the Dermatology Clinical Trials Unit at the Skin & Cancer Foundation Inc in Victoria. She also holds a Master of Applied Science in Chinese Medicine (Acupuncture). Christine joined the ClinTrial Refer team in August 2019 following a merger between her company ‘Clinical Trials Connect’ and ‘ClinTrial Refer’. The move was part of a joint vision to provide a central hub where people could access current clinical trial information. Christine is also the Co-founder and Director of the White Coats Foundation which is a NFP dedicated to supporting the discovery of better health through awareness. She also works one day a week as a Trials Strategy and Development Consultant at The Skin & Cancer Foundation Inc.

Professor John R. Zalcberg OAM, MB BS, PhD, FRACP, FRACMA, FAHMS, FAICD
Head, Cancer Research Program
Monash University, Australia

Professor Zalcberg is currently the Head of the Cancer Research Program as well as NHMRC (MRFF) Practitioner Fellow in the School of Public Health and Preventive Medicine at Monash University - currently overseeing the establishment and activities of clinical quality registries across various tumour types. He is also the inaugural Tony Charlton Chair of Oncology at Alfred Health as well. He was previously the Director, Division of Cancer Medicine, at the Peter MacCallum Cancer Centre in Melbourne from 1997 to 2014 as well as their Chief Medical Officer from 2007 to 2013. He is the current Chair of the Australian Clinical Trials Alliance and serves on the Board of the Australian Red Cross Blood Service. He is immediate past Chair of the Board of AGITG after serving in this role for over 15 years and a past Board Member of Cancer Trials Australia and past Co-Chair of the Cancer Drugs Alliance. Previous positions also include Board Member of the NSW Cancer Institute, President of the Clinical Oncological Society of Australia. He received a Medal of the Order of Australia Award (OAM), the 2011 Cancer Achievement Award from the Medical Oncology Group of Australia and the 2015 Tom Reeve Award for outstanding contribution to cancer care from the Clinical Oncological Society of Australia (COSA). In 2014 the AGITG announced the annual “John Zalcberg OAM Award for Excellence in Australasian Gastro-Intestinal Trials Group (AGITG) Research” in his honour. He has over 280 articles published in peer-reviewed journals and has received funding in excess of $54m over the course of his career.